Mednet Logo
SpecialtiesRadiation Oncology
Radiation Oncology

Radiation Oncology

Expert insights on radiation treatment planning, techniques, toxicity management, and multimodal cancer care.

Recent Discussions

Do you use minimum cutoff values for any PFTs below which you would not offer conventionally fractionated chemoradiation or SBRT for NSCLC?

8
3 Answers

Mednet Member
Mednet Member
Radiation Oncology · Cleveland Clinic

We have historically not used a cut-off lower-limit for FEV1 or DLCO when selecting patients for SBRT for stage I NSCLC. This is supported by both our own (PMID 19487961) and the Indiana University (PMID 18394819) series in which patients were divided into quartiles by baseline PFT's. In both series...

Under what circumstances, if any, would you wait on initiating a TKI for metastatic recurrence of a Stage III NSCLC which occurred while on consolidative durvalumab to minimize pneumonitis risk?

5
2 Answers

Mednet Member
Mednet Member
Medical Oncology · Roswell Park Comprehensive Cancer Center

Hepatotoxicity is of greater concern with ALK/ROS1 inhibitors. ALK inhibitors such as crizotinib or alectinib in combination with anti-PD1/PD-L1 agents led to higher than expected rates of hepatic and/or dermatologic AEs (Spigel et al., PMID 29518553; Kim et al., PMID 35875467). The field has learne...

How do you manage a supraclavicular only recurrence in NSCLC previously treated with chemoradiation for Stage III disease?

3
3 Answers

Mednet Member
Mednet Member
Radiation Oncology · Stanford University School of Medicine

If the patient is otherwise fit and wishes to pursue aggressive therapy, I would consider definitive dose radiation therapy either as consolidation after systemic therapy, or concurrent with systemic therapy.While any recurrence of lung cancer is often a harbinger of systemic progression, a minority...

Would you offer a palliative or more aggressive course of radiation therapy for a symptomatic isolated supraclavicular recurrence of a squamous cell carcinoma of the esophagus?

3 Answers

Mednet Member
Mednet Member
Radiation Oncology · Mayo Clinic School of Medicine

Such early disease progression suggests there was likely occult involvement of the supraclavicular lymph node at the time of initial diagnosis. My decisions on management would hinge upon the extent of initial CRT field.If the supraclavicular lymph node was in field, I would favor a systemic treatme...

Given RADICALS-HD, are you completing 24 mo vs 6 mo of ADT with XRT following RP?

4
2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Levine Cancer Institute

Initial: We know 2 years of ADT works. Adding to the classic RTOG 9601, RADICALS-HD demonstrated an improvement in the primary and clinically-relevant endpoint of MFS.Who should be offered 2 years is a more nuanced question. I rely heavily on the PSA to guide as I am influenced by the significant in...

Would you ever include the proximal seminal vesicles in your prostate SBRT volume?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Karmanos Cancer Institute - McLaren Proton Therapy Center

I tend to include the proximal SVs for my intermediate risk prostate cancer patients getting SBRT. I usually use 8 Gy x5 for the prostate and 5 Gy x5 for the proximal SVs. I use the regimen from a colleague at UCLA and it seems well tolerated.

Given the improved ability to spare heart, kidney and liver, should IMRT be the standard of care for gastric MALT lymphoma (despite the low dose needed to effectively treat these patients)?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Duke University Medical Center

Gastric MALT lymphoma is a tantalizing disease to utilize IMRT. The target is typically irregularly shaped and surrounded by critical normal structures, including the heart, liver, and kidneys. The standard dose for gastric MALT lymphoma is 30 Gy. Thus, one needs to be mindful of dose to all of thes...

How do you approach post-prostatectomy pelvic lymph node only recurrence found on advanced imaging in a patient with a low PSA (~0.5)?

1
2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Precision Radiation Oncology

A lot will depend on the history of the patient. What were the initial parameters at the time of diagnosis (stage, initial PSA, Gleason score)? Were there positive margins at the time of surgery? How long of an interval before the time of recurrence? How was the "lymph node only" recurrence detected...

Is it reasonable to delay radiation therapy following surgical decompression for a patient with spinal cord compression if systemic therapy must be started as soon as possible?

4 Answers

Mednet Member
Mednet Member
Radiation Oncology · Duke University Medical Center

I think it's unwise to delay RT for the usual solid tumor. 1) Surgical decompression seldom removes much tumor. 2) Most of these pts have already received significant chemo decreasing the chances of a meaningful response. 3) A rapid hypofractionated course of RT can usually be given resulting in onl...

What is the role of adjuvant radiation for gastric cancer found to be locally advanced after up-front surgery in the setting of <D2 but R0 resection?

2
2 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of North Carolina at Chapel Hill

I think one has to be very careful making blanket statements regarding management of the type of tumor described. The only real data supporting the standard use of RT in virtually all of these patients was the Macdonald trial from a couple of decades ago (and the patients were often treated three de...